hypericin

hypericin is a lipid of Polyketides (PK) class. Hypericin is associated with abnormalities such as Dermatitis, Phototoxic, Dehydration, Photosensitization, Morphologically altered structure and Myocardial Infarction. The involved functions are known as Cell Cycle Checkpoints, Apoptosis, Acetylation, Cell Survival and Caspase Activation. Hypericin often locates in insoluble fraction, Cytoplasmic matrix, Protoplasm, Tissue membrane and Cytoplasm. The associated genes with hypericin are CDC37 gene, HSPA8 gene, RAF1 gene, cyclin H and FK228. The related lipids are Phosphatidylserines.

Cross Reference

Introduction

To understand associated biological information of hypericin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with hypericin?

hypericin is suspected in Dermatitis, Phototoxic, Photosensitization, Pneumonia, Psoriasis, Phototoxicity, Chronic infectious disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with hypericin

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uterine Cervical Neoplasms D002583 10 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Neoplasms, Radiation-Induced D009381 3 associated lipids
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Skin Neoplasms D012878 12 associated lipids
Burns D002056 34 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Per page 10 20 50 | Total 38

PubChem Associated disorders and diseases

What pathways are associated with hypericin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with hypericin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with hypericin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with hypericin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with hypericin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with hypericin?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with hypericin

Download all related citations
Per page 10 20 50 100 | Total 1000
Authors Title Published Journal PubMed Link
Li JY et al. Management of cutaneous T cell lymphoma: new and emerging targets and treatment options. 2012 Cancer Manag Res pmid:22457602
Zubek S et al. Hypericin and pseudohypericin concentrations of a valuable medicinal plant Hypericum perforatum L. are enhanced by arbuscular mycorrhizal fungi. 2012 Mycorrhiza pmid:21626142
Shi YW et al. [Rapid cloning and functional characterization of hypericin synthase gene]. 2012 Yao Xue Xue Bao pmid:22812015
Huntosova V et al. Development of a new LDL-based transport system for hydrophobic/amphiphilic drug delivery to cancer cells. 2012 Int J Pharm pmid:22814227
Cencic R et al. Inhibitors of translation targeting eukaryotic translation initiation factor 4A. 2012 Meth. Enzymol. pmid:22713332
Huntosova V et al. Cell death response of U87 glioma cells on hypericin photoactivation is mediated by dynamics of hypericin subcellular distribution and its aggregation in cellular organelles. 2012 Photochem. Photobiol. Sci. pmid:22729350
Kairyte K et al. Effective inactivation of food pathogens Listeria monocytogenes and Salmonella enterica by combined treatment of hypericin-based photosensitization and high power pulsed light. 2012 J. Appl. Microbiol. pmid:22469030
Camas N et al. Secondary metabolites of Hypericum leptophyllum Hochst., an endemic Turkish species. 2012 ScientificWorldJournal pmid:22649295
Qian J et al. Preparation of a polyclonal antibody against hypericin synthase and localization of the enzyme in red-pigmented Hypericum perforatum L. plantlets. 2012 Acta Biochim. Pol. pmid:23162805
Olivo M et al. New frontier in hypericin-mediated diagnosis of cancer with current optical technologies. 2012 Ann Biomed Eng pmid:22124793
Van de Putte M et al. Radiolabeled iodohypericin as tumor necrosis avid tracer: diagnostic and therapeutic potential. 2012 Int. J. Cancer pmid:22038886
Weberschock T et al. Interventions for mycosis fungoides. 2012 Cochrane Database Syst Rev pmid:22972128
Spindler SR et al. Novel protein kinase signaling systems regulating lifespan identified by small molecule library screening using Drosophila. 2012 PLoS ONE pmid:22363408
Conner MT et al. Rapid aquaporin translocation regulates cellular water flow: mechanism of hypotonicity-induced subcellular localization of aquaporin 1 water channel. 2012 J. Biol. Chem. pmid:22334691
Richard AJ et al. St. John's Wort inhibits insulin signaling in murine and human adipocytes. 2012 Biochim. Biophys. Acta pmid:22198320
Brechner ML et al. Effects of UV-B on secondary metabolites of St. John's Wort (Hypericum perforatum L.) grown in controlled environments. 2011 May-Jun Photochem. Photobiol. pmid:21275996
Mondon K et al. MPEG-hexPLA micelles as novel carriers for hypericin, a fluorescent marker for use in cancer diagnostics. 2011 Mar-Apr Photochem. Photobiol. pmid:21166812
Buriankova L et al. Kinetics of hypericin association with low-density lipoproteins. 2011 Jan-Feb Photochem. Photobiol. pmid:21114669
Vandepitte J et al. Biodistribution and photodynamic effects of polyvinylpyrrolidone-hypericin using multicellular spheroids composed of normal human urothelial and T24 transitional cell carcinoma cells. 2011 Jan-Feb J Biomed Opt pmid:21280926
Schug TT Targeting transcription through inhibition of TBP. 2011 Jan-Feb Oncotarget pmid:21378415
Morachis JM et al. Identification of kinase inhibitors that target transcription initiation by RNA polymerase II. 2011 Jan-Feb Oncotarget pmid:21378408
Zhao J et al. Plant-derived bioactive compounds produced by endophytic fungi. 2011 Mini Rev Med Chem pmid:21222580
Dinarvand R et al. Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. 2011 Int J Nanomedicine pmid:21720501
Boiy A et al. Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours. 2011 J. Photochem. Photobiol. B, Biol. pmid:21035351
Roelants M et al. Human serum albumin as key mediator of the differential accumulation of hypericin in normal urothelial cell spheroids versus urothelial cell carcinoma spheroids. 2011 Photochem. Photobiol. Sci. pmid:21103512
Sorrentino F et al. Hypericins and thioredoxin reductase: Biochemical and docking studies disclose the molecular basis for effective inhibition by naphthodianthrones. 2011 Bioorg. Med. Chem. pmid:21106380
Li J et al. A dual-targeting anticancer approach: soil and seed principle. 2011 Radiology pmid:21712473
Noell S et al. Selective enrichment of hypericin in malignant glioma: pioneering in vivo results. 2011 Int. J. Oncol. pmid:21399870
Ghazanfarpour M et al. Hypericum perforatum for the treatment of premenstrual syndrome. 2011 Int J Gynaecol Obstet pmid:21315349
Couldwell WT et al. A phase 1/2 study of orally administered synthetic hypericin for treatment of recurrent malignant gliomas. 2011 Cancer pmid:21456013
Patel P et al. Emerging endoscopic and photodynamic techniques for bladder cancer detection and surveillance. 2011 ScientificWorldJournal pmid:22235185
Song S et al. Small-animal PET of tumor damage induced by photothermal ablation with 64Cu-bis-DOTA-hypericin. 2011 J. Nucl. Med. pmid:21498539
Xu M et al. Enhancing hypericin production of Hypericum perforatum cell suspension culture by ozone exposure. 2011 Biotechnol. Prog. pmid:21538976
Sharma KV et al. Photodynamic therapy-induced killing is enhanced in depigmented metastatic melanoma cells. 2011 Cell Biol. Int. pmid:21542806
Engelhardt V et al. Lipophilic rather than hydrophilic photosensitizers show strong adherence to standard cell culture microplates under cell-free conditions. 2011 J. Photochem. Photobiol. B, Biol. pmid:21507674
Mikeš J et al. Lower sensitivity of FHC fetal colon epithelial cells to photodynamic therapy compared to HT-29 colon adenocarcinoma cells despite higher intracellular accumulation of hypericin. 2011 Photochem. Photobiol. Sci. pmid:21298151
Vuong TT et al. Hypericin incorporation and localization in fixed HeLa cells for various conditions of fixation and incubation. 2011 Photochem. Photobiol. Sci. pmid:21243156
Solár P et al. Photoactivated hypericin induces downregulation of HER2 gene expression. 2011 Radiat. Res. pmid:21175347
Ni G et al. The possible use of hypericin to overcome drug resistance in cancer treatment. 2011 Chem. Biol. Interact. pmid:21168397
Barliya T et al. Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapy. 2011 PLoS ONE pmid:21949677
Sačková V et al. Enhanced antiproliferative and apoptotic response of HT-29 adenocarcinoma cells to combination of photoactivated hypericin and farnesyltransferase inhibitor manumycin A. 2011 Int J Mol Sci pmid:22272079
Kammerer R et al. Induction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapy. 2011 PLoS ONE pmid:21738796
Dewaele M et al. Autophagy pathways activated in response to PDT contribute to cell resistance against ROS damage. 2011 J. Cell. Mol. Med. pmid:20626525
Fang R et al. Design and characterization of protein-quercetin bioactive nanoparticles. 2011 J Nanobiotechnology pmid:21586116
Vandepitte J et al. Biodistribution of PVP-hypericin and hexaminolevulinate-induced PpIX in normal and orthotopic tumor-bearing rat urinary bladder. 2011 Cancer Chemother. Pharmacol. pmid:20532886
Cao X et al. Isolation and purification of series bioactive components from Hypericum perforatum L. by counter-current chromatography. 2011 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:21306961
Bánó G et al. On the diffusion of hypericin in dimethylsulfoxide/water mixtures-the effect of aggregation. 2011 J Phys Chem B pmid:21332112
Bhuvaneswari R et al. Antiangiogenesis agents avastin and erbitux enhance the efficacy of photodynamic therapy in a murine bladder tumor model. 2011 Lasers Surg Med pmid:22057493
Sanovic R et al. Low dose hypericin-PDT induces complete tumor regression in BALB/c mice bearing CT26 colon carcinoma. 2011 Photodiagnosis Photodyn Ther pmid:22122915
Mozaffari S et al. Effects of Hypericum perforatum extract on rat irritable bowel syndrome. 2011 Pharmacogn Mag pmid:21969792
Hao PF et al. [Study on the enzyme extraction process of hypericin by pectinase]. 2011 Zhong Yao Cai pmid:22066412
Orčić DZ et al. Antioxidant activity relationship of phenolic compounds in Hypericum perforatum L. 2011 Chem Cent J pmid:21702979
Marysael T et al. Influence of the vascular damaging agents DMXAA and ZD6126 on hypericin distribution and accumulation in RIF-1 tumors. 2011 J. Cancer Res. Clin. Oncol. pmid:21858709
Onoue S et al. In vitro photochemical and phototoxicological characterization of major constituents in St. John's Wort (Hypericum perforatum) extracts. 2011 Phytochemistry pmid:21782201
Crockett SL and Boevé JL Flavonoid glycosides and naphthodianthrones in the sawfly Tenthredo zonula and its host-plants, Hypericum perforatum and H. hirsutum. 2011 J. Chem. Ecol. pmid:21814831
Helmja K et al. Variation in the composition of the essential oils, phenolic compounds and mineral elements of Hypericum perforatum L. growing in Estonia. 2011 Nat. Prod. Res. pmid:21391113
Rainha N et al. Comparison of the endemic Azorean Hypericum foliosum with other Hypericum species: antioxidant activity and phenolic profile. 2011 Nat. Prod. Res. pmid:21246439
Schwarz D et al. Inhibition of 17β-estradiol activation by CYP1A1: genotype- and regioselective inhibition by St. John's Wort and several natural polyphenols. 2011 Biochim. Biophys. Acta pmid:20883830
Park S et al. Immunomodulatory Effects of Hypocrellin A on MHC-restricted Antigen Processing. 2011 Immune Netw pmid:22346783
Shrestha R et al. A high-precision micropipette sensor for cellular-level real-time thermal characterization. 2011 Sensors (Basel) pmid:22164108
Zdunić G et al. Isolation and identification of phenolic compounds from Hypericum richeri Vill. and their antioxidant capacity. 2011 Nat. Prod. Res. pmid:19764002
Cárdenas C et al. Anti-angiogenic and anti-inflammatory properties of kahweol, a coffee diterpene. 2011 PLoS ONE pmid:21858104
Koeberle A et al. Hyperforin, an Anti-Inflammatory Constituent from St. John's Wort, Inhibits Microsomal Prostaglandin E(2) Synthase-1 and Suppresses Prostaglandin E(2) Formation in vivo. 2011 Front Pharmacol pmid:21687502
de Vries E et al. Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. 2011 PLoS Pathog. pmid:21483486
Pimentel MR et al. The use of endophytes to obtain bioactive compounds and their application in biotransformation process. 2011 Biotechnol Res Int pmid:21350663
Crupi R et al. Hypericum perforatum treatment: effect on behaviour and neurogenesis in a chronic stress model in mice. 2011 BMC Complement Altern Med pmid:21272291
Kumagai A et al. A potent inhibitor of SIK2, 3, 3', 7-trihydroxy-4'-methoxyflavon (4'-O-methylfisetin), promotes melanogenesis in B16F10 melanoma cells. 2011 PLoS ONE pmid:22022544
Merhi F et al. Hyperforin inhibits Akt1 kinase activity and promotes caspase-mediated apoptosis involving Bad and Noxa activation in human myeloid tumor cells. 2011 PLoS ONE pmid:21998731
Martirosyan AS et al. Biphasic dose-response of antioxidants in hypericin-induced photohemolysis. 2011 Photodiagnosis Photodyn Ther pmid:21864803
Khan AU et al. Pharmacological studies on Hypericum perforatum fractions and constituents. 2011 Pharm Biol pmid:20738215
Kuliková L et al. NF-κB is not directly responsible for photoresistance induced by fractionated light delivery in HT-29 colon adenocarcinoma cells. 2010 Nov-Dec Photochem. Photobiol. pmid:20718930
Anyzewska M et al. Determination of total hypericins in St. John's wort and herbal medicinal products. 2010 Nov-Dec Acta Pol Pharm pmid:21229872
Kapinus EI [Absorption and fluorescence spectra of hypericin sodium salt in complexes with albumins]. 2010 Mar-Apr Biofizika pmid:20429274
Bhuvaneswari R et al. Evaluation of hypericin-mediated photodynamic therapy in combination with angiogenesis inhibitor bevacizumab using in vivo fluorescence confocal endomicroscopy. 2010 Jan-Feb J Biomed Opt pmid:20210440
Koval J et al. Degradation of HER2 receptor through hypericin-mediated photodynamic therapy. 2010 Jan-Feb Photochem. Photobiol. pmid:19912559
Theodossiou TA et al. Hypericin hydroquinone: potential as a red-far red photosensitizer? 2010 Jan-Feb Photochem. Photobiol. pmid:20003155
Ott M et al. St. John's Wort constituents modulate P-glycoprotein transport activity at the blood-brain barrier. 2010 Pharm. Res. pmid:20229133
Golestani R et al. Small-animal SPECT and SPECT/CT: application in cardiovascular research. 2010 Eur. J. Nucl. Med. Mol. Imaging pmid:20069298
Cui XH et al. Production of adventitious roots and secondary metabolites by Hypericum perforatum L. in a bioreactor. 2010 Bioresour. Technol. pmid:20171884
Nahrstedt A and Butterweck V Lessons learned from herbal medicinal products: the example of St. John's Wort (perpendicular). 2010 J. Nat. Prod. pmid:20408551
Wang D et al. Chemical constituents and antidepressant activity of the new species Hypericum enshiense occurring in China. 2010 Phytomedicine pmid:19699627
Sobolewski C et al. The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies. 2010 Int J Cell Biol pmid:20339581
Bramanti E et al. Effects of hypericin on the structure and aggregation properties of β-amyloid peptides. 2010 Eur. Biophys. J. pmid:20473492
Wang Y et al. Hypericin prolongs action potential duration in hippocampal neurons by acting on K+ channels. 2010 Br. J. Pharmacol. pmid:20233218
Vardapetyan HR et al. Interaction between hypericin and hemoglobin. 2010 J. Photochem. Photobiol. B, Biol. pmid:20634087
Tuna G et al. Inhibition characteristics of hypericin on rat small intestine glutathione-S-transferases. 2010 Chem. Biol. Interact. pmid:20637187
Berlanda J et al. Comparative in vitro study on the characteristics of different photosensitizers employed in PDT. 2010 J. Photochem. Photobiol. B, Biol. pmid:20599390
Wang X et al. Cellular and molecular mechanisms of photodynamic hypericin therapy for nasopharyngeal carcinoma cells. 2010 J. Pharmacol. Exp. Ther. pmid:20551295
da Conceição AO et al. Effect of St. John's Wort standardized extract and hypericin on in vitro placental calcium transport. 2010 J Med Food pmid:20553141
Boiy A et al. Topical treatment of disseminated superficial actinic porokeratosis with hypericin-photodynamic therapy: a case report. 2010 Photodiagnosis Photodyn Ther pmid:20510308
Chang Y and Wang SJ Hypericin, the active component of St. John's wort, inhibits glutamate release in the rat cerebrocortical synaptosomes via a mitogen-activated protein kinase-dependent pathway. 2010 Eur. J. Pharmacol. pmid:20193678
Aboukhatwa M et al. Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease. 2010 Mol Neurodegener pmid:20226030
Karppinen K et al. Optimization of protein extraction from Hypericum perforatum tissues and immunoblotting detection of Hyp-1 at different stages of leaf development. 2010 Mol. Biotechnol. pmid:20563670
Volak LP and Court MH Role for protein kinase C delta in the functional activity of human UGT1A6: implications for drug-drug interactions between PKC inhibitors and UGT1A6. 2010 Xenobiotica pmid:20196639
Prakash DJ et al. Effect of nanohypericum (Hypericum perforatum gold nanoparticles) treatment on restraint stressinduced behavioral and biochemical alteration in male albino mice. 2010 Pharmacognosy Res pmid:21713134
Verfaillie T et al. Linking ER Stress to Autophagy: Potential Implications for Cancer Therapy. 2010 Int J Cell Biol pmid:20145727
Cheng YW et al. Proliferation of retinal pigment epithelial cells induced by (R,R)-XY-10 and (S,S)-XY-10 and their action mechanisms. 2010 Int J Ophthalmol pmid:22553508
Devi VK et al. Importance of novel drug delivery systems in herbal medicines. 2010 Pharmacogn Rev pmid:22228938
Kello M et al. PUFAs enhance oxidative stress and apoptosis in tumour cells exposed to hypericin-mediated PDT. 2010 Photochem. Photobiol. Sci. pmid:20714672
Kim DS et al. Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method. 2010 Healthc Inform Res pmid:21818443